Trial Profile
A Prospective Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion™ (4 mL) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Oct 2022
Price :
$35
*
At a glance
- Drugs DMI 9523 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms STRUT
- Sponsors Ampio Pharmaceuticals
- 26 Mar 2018 According to an Ampio Pharmaceuticals media release, a partial follow up results (3.4-3.7 years) from this study will be presented at a peer-reviewed publication.
- 26 Mar 2018 Results presented in an Ampio Pharmaceuticals media release
- 16 Jan 2018 Detailed results of this study were published in journal Orthopedics in 2017, as reported in an Ampio Pharmaceuticals media release.